Archive for 'Tag Archives: 'Osteonecrosis''
Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners
As part of an expert pan-European consortium* BONE THERAPEUTICS has been awarded a share of the highly competitive Marie Curie grant1 in the amount of €3.8 million. The grant will fund a four-year project entitled BIO-INSPIRE [...]
Updating on the February 15th post, some exciting new developments have recently occurred that further strengthen Bone Therapeutics’ cell product manufacturing capabilities. Following a successful Series D fundraising round, Bone Therapeutics, alongside the Walloon Region and private [...]
Bone Therapeutics completes a €7.7 Million Series D Fundraising round to further advance ongoing PREOB® Phase III clinical trials
Following the approval of the pivotal phase III osteonecrosis trial of PREOB® last November (posted Nov. 9, 2012), Bone Therapeutics has just completed a €7.7 million Series D fundraising round. Of the raised funds, €6.1 million were [...]